Bank of Montreal’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $670M | Sell |
3,078,495
-142,726
| -4% | -$31.7M | 0.25% | 74 |
|
|
2025
Q4 | $736M | Buy |
3,221,221
+245,847
| +8% | +$56M | 0.25% | 77 |
|
|
2025
Q3 | $689M | Buy |
2,975,374
+177,720
| +6% | +$36.2M | 0.26% | 76 |
|
|
2025
Q2 | $519M | Sell |
2,797,654
-671,006
| -19% | -$125M | 0.24% | 76 |
|
|
2025
Q1 | $727M | Sell |
3,468,660
-73,011
| -2% | -$14.2M | 0.35% | 58 |
|
|
2024
Q4 | $629M | Sell |
3,541,671
-526,936
| -13% | -$96.9M | 0.29% | 70 |
|
|
2024
Q3 | $793M | Buy |
4,068,607
+372,630
| +10% | +$69.5M | 0.35% | 60 |
|
|
2024
Q2 | $635M | Buy |
3,695,977
+76,642
| +2% | +$12.7M | 0.18% | 72 |
|
|
2024
Q1 | $653M | Sell |
3,619,335
-331,339
| -8% | -$57.1M | 0.2% | 65 |
|
|
2023
Q4 | $613M | Buy |
3,950,674
+201,181
| +5% | +$29.3M | 0.19% | 74 |
|
|
2023
Q3 | $575M | Buy |
3,749,493
+241,224
| +7% | +$35.4M | 0.2% | 69 |
|
|
2023
Q2 | $487M | Buy |
3,508,269
+484,994
| +16% | +$71.1M | 0.17% | 75 |
|
|
2023
Q1 | $482M | Buy |
3,023,275
+100,023
| +3% | +$15.3M | 0.19% | 76 |
|
|
2022
Q4 | $475M | Buy |
2,923,252
+378,685
| +15% | +$58.1M | 0.21% | 70 |
|
|
2022
Q3 | $366K | Sell |
2,544,567
-360,663
| -12% | -$51.8M | 0.16% | 89 |
|
|
2022
Q2 | $448K | Buy |
2,905,230
+163,107
| +6% | +$24.9M | 0.21% | 82 |
|
|
2022
Q1 | $449M | Sell |
2,742,123
-234,315
| -8% | -$34M | 0.22% | 87 |
|
|
2021
Q4 | $405M | Sell |
2,976,438
-930,047
| -24% | -$110M | 0.22% | 93 |
|
|
2021
Q3 | $426M | Buy |
3,906,485
+215,904
| +6% | +$24.7M | 0.19% | 95 |
|
|
2021
Q2 | $416M | Buy |
3,690,581
+713,407
| +24% | +$80.3M | 0.21% | 91 |
|
|
2021
Q1 | $316M | Sell |
2,977,174
-514,377
| -15% | -$55M | 0.21% | 98 |
|
|
2020
Q4 | $381M | Buy |
3,491,551
+715,141
| +26% | +$68.7M | 0.25% | 88 |
|
|
2020
Q3 | $238M | Buy |
2,776,410
+6,430
| +0.2% | +$605K | 0.2% | 103 |
|
|
2020
Q2 | $271M | Sell |
2,769,980
-661,461
| -19% | -$58.2M | 0.25% | 86 |
|
|
2020
Q1 | $258M | Buy |
3,431,441
+989,433
| +41% | +$84.3M | 0.3% | 74 |
|
|
2019
Q4 | $216M | Sell |
2,442,008
-267,367
| -10% | -$22.2M | 0.16% | 117 |
|
|
2019
Q3 | $205M | Sell |
2,709,375
-1,815,954
| -40% | -$125M | 0.18% | 104 |
|
|
2019
Q2 | $329M | Sell |
4,525,329
-563,327
| -11% | -$44.3M | 0.28% | 74 |
|
|
2019
Q1 | $410M | Buy |
5,088,656
+282,310
| +6% | +$23.1M | 0.35% | 57 |
|
|
2018
Q4 | $443M | Sell |
4,806,346
-403,901
| -8% | -$35.5M | 0.42% | 48 |
|
|
2018
Q3 | $493M | Buy |
5,210,247
+440,501
| +9% | +$41.8M | 0.39% | 53 |
|
|
2018
Q2 | $442M | Sell |
4,769,746
-432,069
| -8% | -$42.2M | 0.36% | 51 |
|
|
2018
Q1 | $492M | Sell |
5,201,815
-202,519
| -4% | -$22.2M | 0.44% | 45 |
|
|
2017
Q4 | $523M | Buy |
5,404,334
+344,838
| +7% | +$32.5M | 0.45% | 42 |
|
|
2017
Q3 | $450M | Buy |
5,059,496
+2,928,287
| +137% | +$223M | 0.41% | 49 |
|
|
2017
Q2 | $155M | Buy |
2,131,209
+186,326
| +10% | +$12.5M | 0.15% | 139 |
|
|
2017
Q1 | $127M | Buy |
1,944,883
+363,976
| +23% | +$22.9M | 0.12% | 161 |
|
|
2016
Q4 | $96.1M | Sell |
1,580,907
-24,521
| -2% | -$1.5M | 0.1% | 180 |
|
|
2016
Q3 | $101M | Buy |
1,605,428
+88,076
| +6% | +$5.7M | 0.11% | 165 |
|
|
2016
Q2 | $93.9M | Buy |
1,517,352
+64,010
| +4% | +$3.9M | 0.11% | 170 |
|
|
2016
Q1 | $83M | Buy |
1,453,342
+102,845
| +8% | +$5.73M | 0.09% | 165 |
|
|
2015
Q4 | $80M | Buy |
1,350,497
+18,939
| +1% | +$1.09M | 0.1% | 166 |
|
|
2015
Q3 | $72.5M | Buy |
1,331,558
+95,983
| +8% | +$6.25M | 0.1% | 187 |
|
|
2015
Q2 | $83M | Buy |
1,235,575
+32,580
| +3% | +$2.13M | 0.1% | 196 |
|
|
2015
Q1 | $70.4M | Sell |
1,202,995
-514,980
| -30% | -$31.1M | 0.08% | 221 |
|
|
2014
Q4 | $112M | Buy |
1,717,975
+96,927
| +6% | +$6.11M | 0.13% | 149 |
|
|
2014
Q3 | $93.6M | Buy |
1,621,048
+90,791
| +6% | +$5.04M | 0.11% | 172 |
|
|
2014
Q2 | $86.4M | Buy |
1,530,257
+288,114
| +23% | +$15.1M | 0.1% | 180 |
|
|
2014
Q1 | $63.8M | Sell |
1,242,143
-469,141
| -27% | -$23.7M | 0.08% | 200 |
|
|
2013
Q4 | $90.4M | Buy |
1,711,284
+514,928
| +43% | +$25.3M | 0.12% | 149 |
|
|
2013
Q3 | $53.5M | Buy |
1,196,356
+242,790
| +25% | +$10.8M | 0.08% | 189 |
|
|
2013
Q2 | $39.4M | Buy |
+953,566
| New | +$41.7M | 0.07% | 213 |
|
Other funds holding ABBV
VCM
VPM
Bank of Montreal's ABBV Position: Q1 2026 in Review
Bank of Montreal reduced its AbbVie (ABBV) stake by 4.4% in Q1 2026, selling an estimated $31.7M and leaving 3,078,495 shares worth $670M. The position accounts for 0.25% of the portfolio, ranked #74.
Bank of Montreal first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $793M in Q3 2024. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Bank of Montreal held 3,078,495 shares of AbbVie worth $670M as of Q1 2026.
- Bank of Montreal sold 142,726 AbbVie shares in Q1 2026, an estimated $31.7M.
- AbbVie made up 0.25% of Bank of Montreal's portfolio in Q1 2026, its #74 holding.
- Bank of Montreal first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Bank of Montreal's AbbVie position peaked at $793M in Q3 2024.
- 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.